Skip to main content
OpenTrials
Completed

NCT Number: NCT03885102

Dialysis Training Therapy: The DiaTT Trial

DiaTT is an interventional, cluster-randomized (1:1), multicenter trial for patients with chronic kidney disease undergoing hemodialysis (n=1,100). This trial will test the effectiveness (by change of sit-to-stand test between baseline and 12 months) of intradialytic exercise training (ET) and health literacy counseling (HLC) for 12 months (Intervention group) in comparison to control group (usual care, UC; no ET, no HLC).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

KfH-Nierenzentrum, Amberg, Bavaria, Germany

Loading trial locations.

About this study

The primary objective of this trial is to assess the effectiveness of intradialytic exercise training (ET) and health literacy counselling (HLC) over 12 months intervention in patients undergoing chronic outpatient hemodialysis as compared to usual care (UC). The primary endpoint is change in Sit-to-Stand (STS60) test, from baseline to after 12 months intervention. The ET consists of both resistance and endurance training, focusing on improving patients' health status and physical functioning. Health literacy counseling aims at improving education, proficiency and self-awareness of the patient.

All patients undergoing hemodialysis in participating centers (clusters) for at least four weeks are eligible to participate in the study. Irrespective of randomized center (cluster) group assignment, all dialysis and overall medical treatments will remain unchanged and follow standard of care and center routine without adaptations to the training intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients ≥ 18 years of age
  • chronic ambulatory hemodialysis for > 4 weeks
  • Written and signed confirmation by the treating dialysis physician that the patient is able to exercise
  • signed informed consent to participation in QiN registry
  • signed informed consent obtained according to confidentiality and data protection regulation, international guidelines and local laws

Exclusion criteria

  • Unstable angina pectoris
  • Uncontrolled arterial hypertension (systolic blood pressure > 180 mmHg or diastolic BP > 105 mmHg on repeated measurements)
  • Uncontrolled tachycardia
  • Acute severe infection
  • Planned live kidney transplantation within the next 12 months
  • Planned conversion to home-hemodialysis or peritoneal dialysis within the next 12 months
  • Dialyzing in long overnight dialysis shift
  • Participation in a regular exercise program during hemodialysis sessions (≥ 1/week) in the last 6 months

Treatment and study plan

Intradialytic exercise intervention

Behavioral

50% aerobic exercise, 50% resistance training thrice a week for 60 min per dialysis session, and health literacy counselling

Usual Care

Behavioral

Usual care with no exercise intervention or health literacy counselling

Primary outcomes

  1. Sit-to-stand test (STS60)

    Time frame: between baseline and 12 months

    Change of Sit-to-stand test (STS 60) (number of repetitions in 60 seconds)

Secondary outcomes

  1. Overall survival

    Time frame: 12 months

    Defined as time from center randomization until death from any cause, or as time from center randomization until the patient was last alive (censored observations).

  2. 3-point MACE

    Time frame: 12 months

    a composite of cardiovascular death, non-fatal stroke, or non-fatal myocardial infarction

  3. sudden death

    Time frame: 12 months

    Patients alive will be considered as censored observations, and death from other causes will be considered as a competing event

  4. Sit-to-stand test (STS60)

    Time frame: 3, 6 and 9 months

    measured in number of repetitions in 60 seconds

  5. Timed-up-and-go test (TUG)

    Time frame: 3, 6, 9, and 12 months

    measured in time (seconds)

  6. Six-Minutes-Walk test (6MWT)

    Time frame: 3, 6, 9, and 12 months

    measured in distance (meter)

  7. Grip strength test (GST)

    Time frame: 3, 6, 9, and 12 months

    measured in kilogram

  8. hospitalizations

    Time frame: 12 months

    measured in number and days of hospitalization for comorbidities

  9. frailty by Multidimensional Prognostic Index (MPI)

    Time frame: 3,6 and 12 months

    measured in change of scale in questionnaire

  10. Serum phosphate

    Time frame: 3, 6, 9 and 12 months

    measured in mmol/L

  11. Erythropoietin dose

    Time frame: 3, 6, 9, and 12 months

    measured in IE/week

  12. Quality of life by SF-36

    Time frame: 3, 6 and 12 months

    measured in change of scale by questionnaire

  13. Health literacy by HLS-EU-Q16

    Time frame: 3, 6 and 12 months

    measured in change of scale in questionnaire

  14. health economics by medication

    Time frame: 12 months

    measured in total costs between between study arms

  15. health economics by hospitalization

    Time frame: 12 months

    measured in days in hospital between between study arms

  16. health economics by transportation

    Time frame: 12 months

    measured in total costs between between study arms

  17. health economics by medical assistance tools

    Time frame: 12 months

    measured in total costs between between study arms

  18. health economics by nursing

    Time frame: 12 months

    measured in total costs between between study arms

  19. health economics by sick leave from workplace

    Time frame: 12 months

    measured in days between between study arms

  20. needle dislocation/ catheter disconnection

    Time frame: 12 months

    number of dialysis needle dislocation/ dialysis catheter disconnection

  21. symptomatic hypotensive episodes

    Time frame: 12 months

    number of symptomatic hypotensive episodes

  22. cramps

    Time frame: 12 months

    number of cramps

Sponsors and collaborators

Lead sponsor

Prof. Dr. med. Martin Halle

Other

Collaborators

  • AOK PLUS
  • BARMER
  • Clinical Trials Unit Freiburg
  • Federal Joint Committee
  • KfH Kuratorium für Dialyse und Nierentransplantation
  • Technical University of Munich
  • Techniker Krankenkasse
  • University Hospital of Cologne

Registry information

Official study title

Exercise During Hemodialysis: The Dialysis Training Therapy (DiaTT) Trial

Acronym: DiaTT

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
Mar 21, 2019
Registry last updated
Dec 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.